Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA's STAMP program

This article was originally published in The Gray Sheet

Executive Summary

Whole blood coagulation test systems will be the focus of a public workshop tentatively scheduled for Aug. 13 in Washington, D.C. as part of FDA's Systematic Technology Assessment of Medical Products program and co-sponsored by the College of American Pathologists. Medical experts, industry reps and regulators have been invited to develop a project proposal for standardization of whole blood coagulation devices. The proposal would be presented to the International Society on Thrombosis and Haemostasis scientific subcommittee on control of anticoagulation at its Aug. 14 meeting in Washington, D.C
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT012028

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel